TY - JOUR
T1 - In vivo neurometabolic profiling in orthostatic tremor
AU - Benito-León, Julián
AU - Louis, Elan D.
AU - Mato-Abad, Virginia
AU - Dydak, Ulrike
AU - Álvarez-Linera, Juan
AU - Hernández-Tamames, Juan Antonio
AU - Molina-Arjona, José Antonio
AU - Malpica, Norberto
AU - Matarazzo, Michele
AU - Romero, Juan Pablo
AU - Sánchez-Ferro, Álvaro
N1 - Publisher Copyright:
© 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved.
PY - 2016
Y1 - 2016
N2 - The pathogenesis of orthostatic tremor (OT) remains unclear, although some evidence points to dysfunction in the brainstem or cerebellum. We used single voxel proton magnetic resonance spectroscopy (1H-MRS) (3 T) to investigate whether neurochemical changes underlie abnormal cerebellar or cortical function in OT. Fourteen OT patients and 14 healthy controls underwent 1H-MRS studies with voxels placed in midparietal gray matter and cerebellum (vermis and central white matter). Spectral analysis was analyzed using the software package LCModel (version 6.3). The absolute metabolite concentrations and ratios of total N-acetylaspartate +N-acetylaspartyl glutamate (NAA), choline-containing compounds, myoinositol, and glutamate+ glutamine to creatine were calculated. In midparietal gray matter spectra, we found a significant decrease in the absolute concentration of NAA in OT patients versus healthy controls (7.76± 0.25 vs 8.11± 0.45, P= 0.017). A similar decrease in NAA was seen in the cerebellar vermis (7.33± 0.61 vs 8.55± 1.54, P= 0.014) and cerebellar white matter (8.54± 0.79 vs 9.95± 1.57, P= 0.010). No differences in the other metabolites or their ratios were observed. Reductions in both cerebral cortical and cerebellar NAA suggest that there is neuronal damage or loss in OT, raising the intriguing question as to whether OT is a neurodegenerative disease. Along with clinical history and electrophysio0logical examination, 1H-MRS could serve as a useful diagnostic aid for OT.
AB - The pathogenesis of orthostatic tremor (OT) remains unclear, although some evidence points to dysfunction in the brainstem or cerebellum. We used single voxel proton magnetic resonance spectroscopy (1H-MRS) (3 T) to investigate whether neurochemical changes underlie abnormal cerebellar or cortical function in OT. Fourteen OT patients and 14 healthy controls underwent 1H-MRS studies with voxels placed in midparietal gray matter and cerebellum (vermis and central white matter). Spectral analysis was analyzed using the software package LCModel (version 6.3). The absolute metabolite concentrations and ratios of total N-acetylaspartate +N-acetylaspartyl glutamate (NAA), choline-containing compounds, myoinositol, and glutamate+ glutamine to creatine were calculated. In midparietal gray matter spectra, we found a significant decrease in the absolute concentration of NAA in OT patients versus healthy controls (7.76± 0.25 vs 8.11± 0.45, P= 0.017). A similar decrease in NAA was seen in the cerebellar vermis (7.33± 0.61 vs 8.55± 1.54, P= 0.014) and cerebellar white matter (8.54± 0.79 vs 9.95± 1.57, P= 0.010). No differences in the other metabolites or their ratios were observed. Reductions in both cerebral cortical and cerebellar NAA suggest that there is neuronal damage or loss in OT, raising the intriguing question as to whether OT is a neurodegenerative disease. Along with clinical history and electrophysio0logical examination, 1H-MRS could serve as a useful diagnostic aid for OT.
KW - Case-control study
KW - Cerebellum
KW - Magnetic resonance imaging
KW - Orthostatic tremor
KW - Pathophysiology
KW - Proton magnetic resonance spectroscopy
UR - http://www.scopus.com/inward/record.url?scp=84991737316&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84991737316&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000004848
DO - 10.1097/MD.0000000000004848
M3 - Article
C2 - 27631243
AN - SCOPUS:84991737316
SN - 0025-7974
VL - 95
JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries
JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries
IS - 37
M1 - e4848
ER -